BiotechTube

Placebo vaginal ring

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Contraception: Optional Applicator for Insertion of Vaginal Ring

Conditions

Contraception: Optional Applicator for Insertion of Vaginal Ring

Trial Timeline

Dec 11, 2014 → Apr 10, 2015

NCT ID
NCT02275546

About Placebo vaginal ring

Placebo vaginal ring is a phase 3 stage product being developed by Organon for Contraception: Optional Applicator for Insertion of Vaginal Ring. The current trial status is completed. This product is registered under clinical trial identifier NCT02275546. Target conditions include Contraception: Optional Applicator for Insertion of Vaginal Ring.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT02275546Phase 3Completed

Other Products from Organon

desloratadineApproved
80
tibolone + raloxifenApproved
80
ezetimibe + statinsApproved
80
losartan potassium + Comparator: carvedilol + Comparator: losartan (+) hydrochlorothiazide (HCTZ) + Comparator: carvedilol (+) hydrochlorothiazideApproved
80
Desloratadine 5 mg + fexofenadineApproved
80